Clinical trials online seminar

This comprehensive seminar explores clinical trials in multiple myeloma from three essential perspectives: the clinician, the researcher, and the clinical trials coordinator.

Haematologist Dr Wojtek Janowski provides a clear, patient-focused overview of what clinical trials are, how they are designed, and what participation involves. He explains the different phases of clinical trials, why they are critical to advancing myeloma treatment, and how patients can access trials in Australia. Dr Janowski also discusses the benefits and risks of trial participation, common misconceptions, and what to expect throughout the screening, consent, treatment, and follow-up process.

Associate Professor Kate Burberry, Deputy Chief Medical Officer at Peter MacCallum Cancer Centre, introduces the concept of teletrials. She explains how digital and remote trial models are expanding access to clinical trials for people living in regional, rural, and remote areas. Using real-world data, she demonstrates how teletrials improve equity, recruitment, and patient experience while maintaining the same safety and governance standards as traditional trials.

Finally, Lisa Fischer, Haematology Clinical Trials Coordinator at Westmead Hospital, offers an in-depth look at the role of the clinical trials nurse and coordinator. She outlines how trials are set up, how patients are supported throughout their trial journey, and what participants can expect in terms of monitoring, communication, and care.

An essential resource for myeloma patients, carers, and families seeking to better understand clinical trials, access emerging treatments, and make informed decisions about trial participation.

Watch on YouTube

Keep watching

Watch our other webinars